Squarepoint’s GeneDx Holdings WGS Stock Holding History
Bought
Maintained
Sold
Other funds holding WGS
CM
CC
AIM
FLAM
Squarepoint's WGS Position: Q2 2026 in Review
Squarepoint sold out of GeneDx Holdings (WGS) in Q2 2026, closing a stake of 24,180 shares — an estimated $1.55M sold.
Squarepoint first reported a position in WGS in Q4 2021 and held it in 13 quarters. The position peaked at $8.39M in Q3 2025. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.
- Squarepoint reported no remaining GeneDx Holdings position as of Q2 2026 after selling out during the quarter.
- Squarepoint sold 24,180 GeneDx Holdings shares in Q2 2026, an estimated $1.55M.
- Squarepoint first reported a position in GeneDx Holdings in Q4 2021 and held it in 13 quarters.
- Squarepoint's GeneDx Holdings position peaked at $8.39M in Q3 2025.
- 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.
Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.